Tag: double seronegative

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

Posted by: The Sumaira Foundation in

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Posted by: The Sumaira Foundation in

Long-term Efficacy of Satralizumab in AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar

Posted by: The Sumaira Foundation in

Izabela’s NMO Story – A Lust For Life

Posted by: The Sumaira Foundation in NMO, Patient, Voices of NMO

May 15, 2021 – a date I’ll never forget, but I didn’t know then that it would change my life in such a drastic way… I woke up feeling nauseous, […]

NMOSD Sieronegativa

Posted by: The Sumaira Foundation in

Partecipa al nostro prossimo Webinar dal titolo: NMOSD sieronegativa – giovedì 27 luglio alle 17.00 con la dr. Elia Sechi, neurologo presso l’Università degli Studi di Sassari. Chi parteciperà di […]

Double sero-negative NMOSD

Posted by: The Sumaira Foundation in

Do you or your loved one continue to test negative for the AQP4 and MOG antibodies? You are not alone!   You’re invited to attend “Double sero-negative NMOSD” on Friday, […]

Jason’s NMO Story – Advocacy and Awareness Saves Lives

Posted by: The Sumaira Foundation in Caregiver, NMO, Voices of NMO

Modern medicine in the United States was a complete failure. For six weeks, the hospitals, doctors, and many lab tests couldn’t piece a single clue together… It was 2018, and […]